Suicide and suicide attempts occur at a significantly greater rate in schizophrenia than in the
general population. Common estimates are that 10% of people with schizophrenia will …

BackgroundDepression in schizophrenia predicts poor outcomes, including suicide, yet the
effectiveness of antidepressants for its treatment remains uncertain. AimsTo synthesise the …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

INTRODUCTION—Depressive symptoms are frequent clinical features in patients with
schizophrenia. Depression is associated with a less favorable patient course and poorer …

The clinical presentation of schizophrenia encompasses symptoms divided into three
dimensions: positive, negative, and cognitive. Negative symptoms (NS), in particular, have a …

This article presents a systematic review of pharmacological treatment for negative
symptoms of schizophrenia, based on MEDLINE searches from 1995 to September 2002 to …

Background. Negative symptoms are a core component of schizophrenia which can
severely impact quality of life and functional outcomes. These symptoms are understood to …

Background Depressive symptoms, often of substantial severity, are found in 50% of newly
diagnosed suffers of schizophrenia and 33% of people with chronic schizophrenia who have …

Background Negative symptoms are common in people with schizophrenia and are often
difficult to treat with antipsychotic drugs. Treatment often involves the use of various add‐on …

Background: Negative symptoms are among the most chronic symptoms of schizophrenia.
Even with the advent of atypical antipsychotic drugs, negative symptoms remain mostly …